Market research reports on:  DNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.

This report focuses on the global market of cell and tissue analysis (CTA) products and provides an updated review, including basic design and applications in various arenas of biomedical and life science research. The report deals with CTA products covering the total market, which includes three main areas of applications. Also included in the report are relevant patent analysis and comprehensive profiles of companies that lead the cell and tissue analysis industry.

• A brief general outlook of the global market for immunoglobulins
• Analyses of the global market trends, with historic market revenue data (sales figures) for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
• Estimation of the actual market size and revenue forecast for the global immunoglobulins market in USD million terms, and corresponding market share analysis by product type, route of administration, and region
• In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, current and future prospects in therapeutic treatments, and contributions to the overall market
• Identification of major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, segmental revenues, and operational integration
• Company profiles of the market leading players

This report represents an in-depth analysis of the global companion diagnostics market by test type, solution, technology, application, and region. This study surveys the CDx market by application into different therapeutic areas. The market is also assessed in three major geographic regions: North America, Europe and Asia-Pacific (APAC). The report concludes with detailed profiles of the major vendors in the global market.

This report provides a comprehensive analysis of CNS biomarkers on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease sub segments to overall industry trends, in order to quantify and qualify the market for products and services in the CNS biomarkers segment. Individual product-types are forecast on a global basis, as are overall segments.

• An overview of the global market and technologies for microbial products with special focus on their applications
• Estimation of the market size and analyses of global market trends, with data from 2021, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
• Highlights of the current and future market potential and quantification of microbial products market based on type, application, and region
• Detailed descriptions of probiotics, their types, and recent developments and information about microbial pesticides and biofertilizers and their potential uses
• Analysis of underlying technological, environmental, legal/regulatory, and political trends that may influence the size and nature of the market
• Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
• Comprehensive company profiles of the leading players of the industry

• An overview of the global market and technologies for next generation cancer diagnostics
• Estimation of the market size and analyses of global market trends, with data from 2021, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
• Highlights of the current and future market potential and quantification of next generation cancer diagnostics market based on type, application, and region
• Description of arrays and microfluidics (LOAC) technologies, multiplex conventional technologies, next generation sequencing technology and polymerase chain reaction (PCR) technology
• Analysis of underlying technological, environmental, legal/regulatory, and political trends that may influence the size and nature of the market
• Coverage of the key initiatives and programs related to the next generation cancer diagnostics market
• Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
• Comprehensive company profiles of the leading players of the industry